News & Highlights

in Cancer

Drew Armstrong of Bloomerg covered results from recent study looking at men whose prostate cancer relapsed and delayed hormone theraphy treatment.

UCSF researchers make an important scientific breakthrough that connects two fundamental cellular processes, protein synthesis and metabolism, important for fueling cancer cell growth. Remarkably, the targeted inhibition of this specific connection caused cancer cells but not normal cells to die, therefore identifying an attractive new approach to cancer therapy.

Study offers new data on hormone therapy timing strategies when prostate cancer relapse is detected by rising PSA levels alone.

The American Association of Genitourinary Surgeons awarded its 2014 Barringer Medal to Peter R. Carroll, MD, MPH, chair of the UCSF Department of Urology ...

Dr. Maurice Garcia, MD, MAS, Assistant Professor of Urology, UCSF designed and developed an implantable fiducial marker for the bladder that allows Radiation Oncologists to visualize and target the tumor site with high-dosages of radiotherapy, and is spearheading ongoing research to develop their role in clinical treatment.

The highly regarded Elsevier practiceupdate.com site recently sought expert commentary from UCSF Urology Chair, Peter Carroll, MD, MPH, for elucidation on results from the Scandinavian Prostate Cancer Study...

Urology faculty member Robert Blelloch, MD, PhD, is leading an NIH-funded project examining the role extracellular RNA (exRNA) might play in prostate and other cancers.

Pages

Tweets

Media Contact

Elizabeth Fernandez
UCSF Department of Urology
San Francisco, CA 94143
[email protected]
415/514-1592